Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Britain’s Anti-Trust Watchdog Studies GlaxoSmithKline Pfizer

By Pharmaceutical Processing | May 27, 2009

LONDON (AP) — Britain’s competition watchdog said Wednesday that it will investigate plans by drug maker GlaxoSmithKline PLC to pool resources with Pfizer Inc. to create a new company to develop and sell HIV medicines. The Office of Fair Trading said it will decide whether the joint venture can be considered to be a merger that will reduce competition in the UK. It also will decide whether to refer the case to the Competition Commission regulators, which have the power to block or put limits on the deal. The OFT said interested parties had until June 9 to submit their views for the first stage of consultations. GlaxoSmithKline, the world’s second largest drug maker by revenues, said last month that it plans to form a new company with Pfizer Inc. that will blend Galaxo’s portfolio of HIV drugs now on the market — some with patents approaching expiration — with New York-based Pfizer’s more robust pipeline of drugs in development. With 11 HIV medicines already on sale, the new venture would have a 19 percent market share, ranking it No. 2 behind sales leader Gilled Sciences Inc. Other competitors in the field include heavyweights Bristol-Myers Squibb Co., Abbott Laboratories, Merck & Co. and Dumont Pharmaceuticals Co.

Related Articles Read More >

GSK
GSK invests another $800M in Pennsylvania site expansions
This is a BD image of its major IV catheters manufacturing facility in Sandy, Utah, which the company said produces billions of molded components each year.
BD to invest billions in U.S. manufacturing
Diverse factory workers in yellow PPE suits checking production data with clipboard in modern industrial facility, Quality control inspector wearing masks and hairnets working in food or pharma plant
ISO 9001, 14001 and 45001 revisions: What changes and when to start
Artis BioSolutions announces new center of excellence in Spain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE